Boston, MA -- (SBWIRE) -- 01/02/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: ALACER GOLD CORP(OTCMKTS:ALIAF), Applied DNA Sciences Inc(OTCMKTS:APDN), Generex Biotechnology Corporation(OTCMKTS:GNBT), Affymax, Inc.(OTCMKTS:AFFY)
ALACER GOLD CORP(OTCMKTS:ALIAF) opened its shares at the price of $2.01 for the day. Its closing price was $2.05 after gaining +3.59% for the day. The company traded with the total volume of 71,835.00 shares, while its average trading volume remained 116,330.00 shares. The beta of ALIAF stands at 0.14. Alacer Gold Corp., an intermediate gold mining company, engages in the exploration and production of gold in Australia and Turkey.
For How Long ALIAF will Fight for Profitability? Read This Trend Analysis report
Applied DNA Sciences Inc(OTCMKTS:APDN) percentage change surged +2.97% to close at $0.163 with the total traded volume of 1.24 million shares, and average volume of 2.89 million. The 52 week range of the stock remained $0.08 - $0.28, while its day lowest price was $0.15 and it hit its day highest price at $0.16. Applied DNA Sciences, Inc. provides botanical-DNA based anti-counterfeiting and product authentication solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe, and Asia.
For How Long APDN’s Gloss will Attract Investors ? Find out via this report
Generex Biotechnology Corporation(OTCMKTS:GNBT) started its trading session with the price of $0.03 and closed at $0.0286 by scoring +2.88%. GNBT’s stocks traded with total volume of 1.70 million shares, while the average trading volume remained 1.76 million shares. The beta of GNBT stands at 2.13. Day range of the stock was $0.03 -$0.03. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Continue To Move Higher? Find Out Here
Affymax, Inc.(OTCMKTS:AFFY) ended its day with the gain of +2.55% and closed at the price of $0.780 after opening at $0.76. Stock traded during its last trading session with the total volume of 784,923.00 shares, as compared to its average volume of 278,805.00 shares. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Why Should Investors Buy AFFY After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)